Methods. M abscessus-associated odontogenic infections occurred in a group of children after they each underwent a pulpotomy. A probable case-child was defined as a child with facial or neck swelling and biopsy-confirmed granulomatous inflammation after a pulpotomy between October 1, 2013, and September 30, 2015. M abscessus was isolated by culture in confirmed case-children. Clinical presentation, management, and outcomes were determined by medical record abstraction.
Nontuberculous mycobacterial (NTM) species are ubiquitous in environmental sources such as soil and water, including municipal drinking water systems, hospital water systems, and household plumbing [1] . The Centers for Disease Control and Prevention (CDC) has published guidelines for water-filtration systems, monitoring, and treatment for preventing healthcare-associated infections [2] . Mycobacterium abscessus, a rapid-growing multidrug-resistant mycobacterium, is an uncommon source of healthcare-associated infections. Infections have been associated with the use of M abscessus-contaminated water or equipment during tympanostomy tube placement [3] [4] [5] , gastrostomy tube placement [6] , laparoscopy [7] , acupuncture [8] , lung transplantation [9] , liposuction [10] , abdominoplasty [11] , brain biopsy [12] , and rhytidectomy [13] . Before 2016, there was only 1 report of an M abscessus infection after a dental procedure in Israel (in a 19-year-old child who developed mandible osteomyelitis after a root canal) [14] . The report did not comment on the association of water-supply contamination during the child's dental procedure or her development of infection.
The goal of a pulpotomy is to remove infected nerve or pulp tissue to prevent a tooth abscess and to preserve tooth space for secondary tooth eruption. The adult equivalent to a pulpotomy is a root canal. However, an adult root canal is considered a surgical procedure, and sterile or treated water is used [2, 15, 16] . A pulpotomy is considered a nonsurgical procedure, and municipal water is often used for drilling and irrigation. In its guidelines for infection prevention in dental clinics, the CDC recommends that municipal water meet microbiologic standards for drinking water before use in nonsurgical dental procedures [2] . Multiple cases of odontogenic M abscessus lymphadenitis were observed in school-aged children in the Atlanta, Georgia, area, most of whom had extranodal manifestations, including mandibular or maxillary osteomyelitis with or without pulmonary nodules, after recent pulpotomy restorative dental procedures. An outbreak investigation was conducted, and the clinical presentation, treatment, and outcomes are reported here.
METHODS
In early 2014, a cluster of 5 children with subacute submandibular and cervical lymphadenitis with or without jaw swelling presented for tertiary medical care at 1 of 2 children's hospital in Atlanta. Because each of these children presented with subacute lymphadenitis, an atypical pathogen was suspected. In these initial case-children, a lymph node biopsy was performed and microbiologic cultures were obtained. The pathologic specimens revealed granulomatous inflammation with or without microbiologic isolation of M abscessus. Because of these results, pediatric infectious disease physicians suspected a common source. Detailed histories revealed that each of the children had undergone a pulpotomy procedure at common dental practice. An epidemiologic investigation was initiated in conjunction with the Georgia Department of Public Health (GDPH) [17] . A probable case-child was defined as a child with facial or neck swelling and biopsy-confirmed granulomatous inflammation after a pulpotomy performed between October 1, 2013, and September 30, 2015. Confirmed case-children met the probable case-child definition and had M abscessus isolated by culture from a surgical specimen. All confirmed and probable case-children were treated at the same pediatric dental practice.
Active surveillance was implemented to optimize case finding (GDPH officials, personal communication, September to January 2016). The dental practice, community physicians, and the GDPH collaborated to inform potentially exposed families about these infections and to increase healthcare utilization and general community awareness. All of the children with significant infections were identified and referred for tertiary medical care. Medical records of children with a histopathologic specimen that revealed granulomatous inflammation or a microbiologic culture that grew M abscessus (from the Georgia Public Health Laboratory and clinical laboratories of the local pediatric healthcare system) were reviewed (GDPH officials, personal communication, September to January 2016). Children who were identified were evaluated by a pediatric subspecialist at 1 of 2 local pediatric hospitals. Clinical, radiographic reports, pathologic specimen results, and microbiologic culture results, antibiotic treatment regimens, and outcomes were abstracted from the medical records using a uniform case-report form.
The time to illness onset (determined by hospital chart review and parent reports), was defined as the time from the child's first pulpotomy to his or her seeking medical care at a tertiary pediatric hospital. The time from illness onset to presentation was defined as the time from symptom onset to the time of presentation at a tertiary pediatric hospital where definitive care was received. The diagnosis of lymphadenitis was suspected on the basis of physical examination findings and confirmed with pathologic examination of lymph tissue containing granulomatous inflammation. Associated osteomyelitis was suspected on the basis of radiologic imaging that revealed a periosteal reaction or osteolytic changes and confirmed on pathologic examination of bone tissue that revealed granulomatous inflammation and associated acute or chronic inflammation. Pulmonary nodules were an incidental radiographic finding from computed tomography (CT) imaging of the neck. A single child underwent a lung biopsy, which confirmed the association of a disseminated M. abscessus infection based on the pathologic examination of tissue obtained via lung biopsy that revealed granulomatous inflammation. Mycobacterial cultures were prepared locally, and species identification was performed at the GDPH laboratory or at 1 of 2 reference laboratories. Susceptibility testing was performed at 1 of 2 reference laboratories. Incomplete resection was defined as the presence of residual granulomatous tissue at the site of infection. Morbidities associated with a surgical procedure or medical treatment for the M. abscessus infection in these children included central venous line complication, permanent tooth loss, aminoglycoside-associated high-frequency hearing loss, facial nerve palsy, urticarial rash, elevated liver enzyme levels, acute kidney injury, incision dehiscence/fibrosis, and neutropenia.
Statistical analysis was performed using SAS 9.4 (SAS, Inc, Cary, NC). The Emory University School of Medicine and Children's Healthcare of Atlanta institutional review boards considered this study exempt from review.
RESULTS
Between October 24, 2013, and September 18, 2015, 1062 children underwent a pulpotomy at a common dental practice, and 24 of them met the probable-case-child definition, which equates to an attack rate of 2.3%. Of these 24 (58%) children, 14 were confirmed case-children, and 10 (42%) were probable case-children.
Representatives from the GDPH visited the dental practice and confirmed that municipal water was used for drilling and irrigation during pulpotomies. The water was used to remove the infected portion of the vital pulp, after which, prepackaged ferric sulfate was applied with a sterile disposable brush to stop the bleeding. The tooth cavity was stabilized with glass ionomer cement before the placement of a metal crown. The GDPH found that the dental practice flushed its waterlines without the use of disinfectant and that the suction tubing was sterilized at the end of each day and changed every 1 to 2 years. The clinic did not perform active water-monitoring procedures (GDPH officials, personal communication, September to January 2016) [2, 17] . The CDC guideline recommends that water used in nonsurgical dental procedures meet the Environmental Protection Agency's microbiologic cut-off safety standard for drinking water (which is ≤500 CFU/mL of heterotrophic water bacteria) [2] . At the time of the epidemiologic investigation, microbiologic testing of the water at the dental chairs revealed an average M abscessus level of 91 333 CFU/mL (>180 times the recommended maximum level) [2] . Mycobacterium gordonae and Mycobacterium szulgai also were identified in cultures of the dental clinic's water supply at a microbiologic level ranging from <10 to 100 CFU/ mL. Because the levels of these mycobacteria were below the Environmental Protection Agency's safety cut-off value of <500 CFU/mL, and neither was isolated in the clinical specimens, they were not considered pathogenic. Thirteen dental chair water sample isolates from 7 dental chairs and 8 tissue sample isolates from 7 children were identified by the CDC as indistinguishable according to pulsed-field gel electrophoresis, which suggests a common source. The GDPH recommended that the dental practice no longer use municipal water during pulpotomies but to use distilled chlorinated water instead (GDPH officials, personal communication, September to January 2016). After the dental practice's change in procedure with this recommendation implemented, no other cases have been reported.
The median age at the encounter for which definitive care was provided was 7.3 years (interquartile range, 5.8-8.2 years), and a similar distribution of infections was found among boys and girls; all the children had a history of poor dentition (Table 1) . No child had a documented underlying immunodeficiency. The median time to symptom onset was 74 days (range, 14-262 days). Each child had received at least 1 course of empiric antimicrobial therapy before his or her presentation for definitive management. The median time from symptom onset to presentation was 29 days (range, 5-108 days). The most common presenting symptoms included submandibular swelling, jaw swelling, gum swelling, and tooth pain. One child presented with systemic symptoms of fever, weight loss, and erythema nodosum. None of the children had respiratory symptoms (Table 1) .
All the children underwent radiologic imaging. Contrasted maxillofacial CT of the head or neck or magnetic resonance imaging of the head and neck were used to identify associated osteolytic or periosteal changes of the adjacent mandible or maxilla and to guide surgical intervention. Pulmonary nodules were identified incidentally on CT imaging of the neck (Figure 1 Each child required hospitalization and at least 1 surgical debridement/tissue excision. The average number of total hospital days was 8 (range, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , and the median number of surgical procedures was 2 (range, 1-6). The surgical procedures included partial or complete resection of lymphadenitis with or without mandible/maxilla debridement and tooth extraction; 1 child underwent a pulmonary nodule biopsy. Twelve (50%) children were treated with complete resection alone. Indications for repeat surgery are described in Table 2 . Two children with extensive cervical lymphadenitis required a bilateral total neck dissection. The children with incomplete resection had lymph node tissue adherent to the facial nerve, and removing this tissue would have risked complete and irreversible facial palsy on the affected side. Many children had 1 or more adverse events related to their surgical procedure, including permanent tooth loss, temporary facial nerve palsy, and incision dehiscence or scar fibrosis (Table 2) .
Tissue specimens from 10 (42%) children were acid-fast bacillus smear positive, and 14 (58%) had M abscessus isolated from culture. Susceptibility testing was performed on 11 (79%) of 14 M abscessus isolates. All of the isolates were susceptible to amikacin. Isolate susceptibility to macrolides (azithromycin and clarithromycin) was determined by microtiter minimum inhibitory concentration testing at 3 days of culture growth. Inducible macrolide resistance was identified by microtiter testing at 14 days of culture growth. Molecular testing confirmed the presence of the erm41 gene, which confers inducible macrolide resistance. Of 11 isolates, 5 (45%) were susceptible to cefoxitin; the remainder of the isolates had intermediate cefoxitin susceptibility (Table 3) . Twelve children received antibiotic therapy. One child underwent lymph node resection, was treated with oral clarithromycin monotherapy for 4 months, and did not experience infection recurrence. Eleven (46%) children with incomplete surgical excisions or pulmonary nodules underwent postsurgical IV antibiotic therapy. Treatment regimens included amikacin (10-30 mg/kg every 24 hours), cefoxitin (100-160 mg/kg per day divided every 8 hours) with or without oral azithromycin (5-10 mg/kg per day every 24 hours), or oral clarithromycin (20 mg/kg per day divided every 12 hours). The median duration of antibiotic treatment was 16 weeks (range, 4-24 weeks); 3 children received 6 months of IV therapy with or without an oral macrolide [18] . All children who received IV therapy underwent weekly laboratory monitoring, which included a complete blood count and basic metabolic panel. Some children were monitored with liver function and weekly amikacin level testing.
Of the 11 children who received IV antibiotic therapy, 7 (64%) had a vascular access catheter malfunction, which included thrombus formation, dislodgement, or inadvertent child removal. Of 12 children, 8 (67%) experienced morbidity associated with antibiotic administration, including urticarial rash (n = 3), elevated liver enzyme levels (n = 1), or neutropenia (n = 1), which led to either an unintended discontinuation of cefoxitin therapy (n = 3) or a brief discontinuation of cefoxitin followed by a successful reintroduction of the antibiotic (n = 2).
Nine (82%) of 11 children who received amikacin underwent a monthly follow-up hearing evaluation. Two children experienced reversible amikacin-induced acute kidney injury, and 5 (56%) of the 9 children tested experienced sustained irreversible high-frequency hearing loss that led to premature discontinuation of amikacin. 
Indications for repeat surgical intervention (n/N [%])
Persistence of lymphadenitis after initial excisional biopsy or incision and drainage
(29)
Persistence of lymphadenitis after osteomyelitis debridement 6/11 (55)
Repeat debridement at site of osteomyelitis 3/11 (27) Incision dehiscence 1 (4)
Surgical site abscess formation 1 (4)
Central venous line placement/removal 3/11 (27) Complications Six (50%) of 12 children underwent end-of-treatment imaging. For 3 children, resolution of the initial imaging findings was found; for the remaining 3 children, there were persistent imaging findings, including submandibular soft tissue swelling (n = 1) and residual but smaller pulmonary nodules (n = 2).
After their final surgical procedure and/or surgical plus medical management, all of the children remained without infection recurrence through at least 6 months.
DISCUSSION
M abscessus is an uncommon cause of head and neck infection in children [19] [20] [21] [22] . More than 70% of pediatric cases of NTM lymphadenitis are caused by Mycobacterium avium complex (MAC), a group of slow-growing nontuberculous mycobacteria. MAC lymphadenitis occurs in young children (median age, 3.4 years), who develop unilateral submandibular lymph node swelling that is slow to progress (over 4-8 weeks), unresponsive to empiric antimicrobial therapy, and not associated with osteomyelitis or pulmonary nodules [19] [20] [21] [22] [23] . This outbreak of odontogenic M abscessus head and neck infections affected school-aged children, most of whom had extranodal manifestations, including osteomyelitis with or without pulmonary nodules. We speculate that the severity of these infections might have been related to the virulence of the pathogen in addition to the introduction of a high M abscessus inoculum at the site of the infection during the pulpotomy procedure. Only 1 of 7 children with pulmonary nodules presented with systemic symptoms (fever and weight loss), and none of the children had respiratory symptoms. In children who had end-of-treatment CT chest imaging, the pulmonary nodules had decreased in size, but none had resolved completely, which suggests that antibiotic therapy might have had little impact on the pulmonary nodules, and their clinical significance remains unclear.
Guidance regarding optimal management of M abscessusassociated NTM lymphadenitis is limited. Most studies address management of MAC followed by Mycobacterium haemophilum or Mycobacterium scrofulaceum lymphadenitis, and few have described management of M abscessus or another rapid-growing mycobacterium-associated infection [19] [20] [21] [22] . Excision, when feasible, is the management of choice [24] [25] [26] . Complications of resection include the risk of facial nerve injury, wound dehiscence, and scar fibrosis [24] [25] [26] . Furthermore, studies have found that antimicrobial treatment of NTM lymphadenitis does not result in resolution that is more rapid than that after resection alone [27] [28] [29] . An observational study found spontaneous resolution of pediatric NTM lymphadenitis in 10 to 12 months without medical or surgical treatment. However, in that cohort, 90% of the children had either MAC or Mycobacterium haemophilum isolated on culture, and less than 5% of the children had M abscessus-associated NTM lymphadenitis [29] . The authors of that report did not comment on the association of NTM species with clinical outcome. On the basis of our experience, M abscessus might be associated with more severe manifestations of infection. Current Infectious Disease Society of America/ American Thoracic Society guidelines for the management of M abscessus-associated skin, soft tissue, and bone infections suggest management with a combination of surgical debridement and adjunctive antibiotic therapy for 4 to 6 months [18] .
In our cohort, 12 (50%) of the children with limited infection were treated with surgery alone. The remaining 12 children, with incomplete resection of cervical lymph node tissue and/or the presence of pulmonary nodules, received antibiotic therapy after surgical debridement. One child received 4 months of oral clarithromycin alone. The effect of this adjunctive antibiotic treatment (either combination or monotherapy) on clinical outcome is unknown. The choice of an antibiotic treatment regimen for M abscessus-associated pediatric infection was limited by multidrug resistance, antibiotic toxicity, and a lack of randomized controlled trials on the best treatment regimens for M abscessus-associated infection. In our cohort, children were treated with IV amikacin and IV cefoxitin with or without an oral macrolide for a median of 4 months [18] . Of the 11 clinical isolates that were sent for resistance testing, 6 (55%) were found to have intermediate susceptibility to cefoxitin, which guided clinicians to use high-dose cefoxitin therapy (up to 160 mg/kg per day divided every 8 hours) but might have increased the risk of antibiotic-associated drug toxicity (neutropenia) or a reaction (rash or elevated liver enzyme levels). All of the isolates were susceptible to macrolide (both azithromycin Ten (91%) of 11 of isolates were resistant to ciprofloxacin, and 2 (18%) of 11 isolates were resistant to linezolid.
and clarithromycin) therapy on the basis of isolate microtiter susceptibility testing at 3 days of culture growth; however, macrolide resistance was detected at 14 days of culture growth. Molecular testing of the M abscessus clinical isolates revealed the presence of the erm41 gene, which confers inducible macrolide resistance. Reports have associated the presence of the erm41 gene in clinical M abscessus isolates from pulmonary specimens with poor clinical outcome [30, 31] . The influence of the addition of clarithromycin or azithromycin on clinical outcomes in our cohort is unknown [31] ; few alternative antimycobacterial treatment agents were available. All of the isolates were susceptible to tigecycline (which was not recommended for our child population because of its effects on tooth development [23] ) and clofazimine (which was not readily available for clinical use). Medical management was not well tolerated. Five (42%) of the 12 children experienced an adverse event that led to a modification of their initial treatment regimen. The most commonly reported adverse events in our experience were similar to those noted in previous studies (eg, nephrotoxicity [including acute renal failure], ototoxicity, antibiotic-associated rash, and neutropenia). Other studies also found that these events led to discontinuation or replacement of the initial antibiotic regimen [9] [10] [11] .
The dental practice's lack of regular water monitoring led to the unintentional use of municipal water that had a high concentration of M abscessus during pediatric pulpotomies. Because of the unusual presentation of school-aged children with M abscessus lymphadenitis after restorative dental procedures, an epidemiologic investigation was initiated. Despite active measures to improve the identification of infected children, most case-children experienced delays in referral and definitive management. Variations in clinical presentation and prolonged time to seeking medical care contributed to the challenges to medical and surgical management. After the clinic's use of treated distilled water during pulpotomies, no other cases occurred.
We acknowledge limitations of our report. Clinical data were extracted from electronic medical records. Physician variability was observed in the documentation of the clinical course, surgical procedures, and management decisions.
CONCLUSION
The 24 children in this dental care-associated M abscessus outbreak experienced significant medical and surgical morbidity. The association of M abscessus infection and restorative dental procedures should be considered in children who present with subacute cervical lymphadenitis. Unique clinical manifestations included extranodal manifestations of mandibular and maxillary osteomyelitis and pulmonary nodules. Early identification with complete resection led to clinical cure. The risks of resection included permanent tooth loss, temporary facial nerve palsy, and incision dehiscence/fibrosis. Medical therapy was limited by the available antimycobacterial agents for treatment and complicated further by adverse effects related to antibiotics and the vascular access needed for their administration. Dental procedure-associated M abscessus odontogenic infection can be prevented by the use of sterile or treated water during pediatric restorative dental procedures, as is the routine practice for adults.
Notes

